CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development

2026-03-10 - 12:37

HONG KONG SAR – Media OutReach Newswire – 10 March 2026 – CK Life Sciences Int’l., (Holdings) Inc. (“CK Life Sciences” or the “Company”, Stock Code: 0775) today announced the establishment of Sequencio Therapeutics (“Sequencio”), a wholly-owned subsidiary dedicated to advancing the Company’s therapeutic cancer vaccine portfolio. The Third Pillar of a Strategic Reorganisation This